R01 AI 145265 (Peebles)

NIH/NIAID

“PGI2 regulates Treg function”

Duration: 04/01/2019-03/31/2024

Current Year Direct Cost: $315,060

This project will determine the mechanisms by which signaling through the prostaglandin (PG)I2 receptor promotes immune tolerance to aeroallergen-induced inflammation.

I01 BX 004299 (Peebles)

Merit Review Award  

Department of Veterans Affairs

“PGI2 inhibition of pulmonary innate allergic immune responses”

Duration:  10/01/18 – 09/30/22

Current Year Direct Cost:  $198,000

This project will determine the mechanisms by which PGI2 regulates IL-33 expression and release to inhaled allergen.

U19 AI 095227 (Peebles)

NIH/NIAID

“Host and Viral Determinants of Infant and Childhood Allergy and Asthma”

Duration:  08/01/16 – 07/31/26

Current Year Direct Cost: $1,082,276

RSV is the leading cause of bronchiolitis and causes >100,000 infant hospitalizations in the US each year.  Studies have also revealed that severe RSV infection in infancy is associated with the later development of childhood asthma.  This application will examine the effects of both host genetic and immune response determinants, as well as the influence of specific RSV strains on severity of RSV bronchiolitis and childhood asthma.  The long-term objective of this proposed project is to define the relationship between infant respiratory syncytial virus (RSV) infection and the host response that enables asthma inception.